These data on the anti-cancer activity of RX-8243 will be presented in a poster (abstract #3562) entitled, “Characterization of a novel small molecule with potent anticancer activity,” on Tuesday, April 20, 2010, from 9:00 am – 12:00 pm EDT in Exhibit Hall A-C, Poster Section 24, during the “Experimental and Molecular Therapeutics” session.
update on their cancer drug...if findings are positive should be a nice pop in the pps, however if not i am not really sure what will happen...my guess would be it goes back down to the mid-high dollar range
Market Data 
Markets 
AI
